These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15664693)

  • 1. Effects of neonatal and prepubertal hormonal manipulations upon estrogen neuroprotection of the nigrostriatal dopaminergic system within female and male mice.
    Anderson LI; Leipheimer RE; Dluzen DE
    Neuroscience; 2005; 130(2):369-82. PubMed ID: 15664693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental and genetic influences upon gender differences in methamphetamine-induced nigrostriatal dopaminergic neurotoxicity.
    Dluzen DE; McDermott JL
    Ann N Y Acad Sci; 2004 Oct; 1025():205-20. PubMed ID: 15542719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of estrogen upon methamphetamine-induced neurotoxicity within the impaired nigrostriatal dopaminergic system.
    Liu B; Dluzen DE
    Synapse; 2006 Oct; 60(5):354-61. PubMed ID: 16838362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of estrogen and related agents upon methamphetamine-induced neurotoxicity within an impaired nigrostriatal dopaminergic system of ovariectomized mice.
    Liu B; Dluzen DE
    Neuroendocrinology; 2006; 83(5-6):295-302. PubMed ID: 16926530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent influences of sex steroids of systemic and central origin in a rat model of Parkinson's disease: A contribution to sex-specific neuroprotection by estrogens.
    Gillies GE; McArthur S
    Horm Behav; 2010 Jan; 57(1):23-34. PubMed ID: 19538962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effects of estrogen upon methamphetamine induced neurotoxicity of the nigrostriatal dopaminergic system.
    Gajjar TM; Anderson LI; Dluzen DE
    J Neural Transm (Vienna); 2003 Nov; 110(11):1215-24. PubMed ID: 14628187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-response effects of estrogen and tamoxifen upon methamphetamine-induced behavioral responses and neurotoxicity of the nigrostriatal dopaminergic system in female mice.
    Mickley KR; Dluzen DE
    Neuroendocrinology; 2004; 79(6):305-16. PubMed ID: 15256808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender differences in modulatory effects of tamoxifen upon the nigrostriatal dopaminergic system.
    Dluzen DE; Mickley KR
    Pharmacol Biochem Behav; 2005 Jan; 80(1):27-33. PubMed ID: 15652377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of testosterone upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system of C57/B1 mice.
    Dluzen DE
    Brain Res; 1996 Apr; 715(1-2):113-8. PubMed ID: 8739629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of testosterone upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system.
    Gao X; Dluzen DE
    Brain Res; 2001 Feb; 892(1):63-9. PubMed ID: 11172749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striatal dopamine output is compromised within +/- BDNF mice.
    Dluzen DE; Anderson LI; McDermott JL; Kucera J; Walro JM
    Synapse; 2002 Feb; 43(2):112-7. PubMed ID: 11754489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex differences in methamphetamine-evoked striatal dopamine output are abolished following gonadectomy: comparisons with potassium-evoked output and responses in prepubertal mice.
    Dluzen DE; Salvaterra TJ
    Neuroendocrinology; 2005; 82(2):78-86. PubMed ID: 16415598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen, testosterone, and methamphetamine toxicity.
    Dluzen DE; McDermott JL
    Ann N Y Acad Sci; 2006 Aug; 1074():282-94. PubMed ID: 17105924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine transporter as a marker of neuroprotection in methamphetamine-lesioned mice treated acutely with estradiol.
    D'Astous M; Gajjar TM; Dluzen DE; Di Paolo T
    Neuroendocrinology; 2004; 79(6):296-304. PubMed ID: 15249736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen, anti-estrogen, and gender: differences in methamphetamine neurotoxicity.
    Dluzen DE; McDermott JL
    Ann N Y Acad Sci; 2002 Jun; 965():136-56. PubMed ID: 12105091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methamphetamine-gonadal steroid hormonal interactions: effects upon acute toxicity and striatal dopamine concentrations.
    Dluzen DE; Anderson LI; Pilati CF
    Neurotoxicol Teratol; 2002; 24(2):267-73. PubMed ID: 11943514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of gender and the neurotrophin, BDNF, upon methamphetamine-induced neurotoxicity of the nigrostriatal dopaminergic system in mice.
    Dluzen DE
    Neurosci Lett; 2004 Apr; 359(3):135-8. PubMed ID: 15050682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex dimorphisms in the neuroprotective effects of estrogen in an animal model of Parkinson's disease.
    Gillies GE; Murray HE; Dexter D; McArthur S
    Pharmacol Biochem Behav; 2004 Jul; 78(3):513-22. PubMed ID: 15251260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striatal susceptibility to a dopaminergic neurotoxin is independent of sex hormone effects on cell survival and DAT expression but is exacerbated by central aromatase inhibition.
    McArthur S; Murray HE; Dhankot A; Dexter DT; Gillies GE
    J Neurochem; 2007 Feb; 100(3):678-92. PubMed ID: 17116232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats: differential actions of estrogen in males and females.
    Murray HE; Pillai AV; McArthur SR; Razvi N; Datla KP; Dexter DT; Gillies GE
    Neuroscience; 2003; 116(1):213-22. PubMed ID: 12535954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.